Select Bibliography

Filter by any of these (after searching):

AUTHOR ABSTRACT DEADLINES

A meeting abstract must be submitted by the first or corresponding author to the Alliance Publications Coordinator (publications@AllianceNCTN.org) at least two weeks prior to the meeting abstract submission deadline. For detailed information about Alliance Publications guidelines, please refer to the policies, along with the author abstract deadlines.

There are 70 items

Challenges and Gaps in Clinical Trial Genomic Data Management.

Asad, Sarah , Kananen, Kathryn , Mueller, Kurt R , Symmans, W Fraser ... - - JCO Clin Cancer Inform - 2022

Manuscript - No-Endpoint - Other - PPP - No Study Assigned

A Genome-Wide Association Study Identifies Novel Loci for Paclitaxel-Induced Sensory Peripheral Neuropathy in CALGB 40101

Baldwin, R. Michael , Owzar, Kouros , Zembutsu, Hitoshi ... - - Clin. Cancer Res. - 2012

Manuscript - Secondary-not-in-original - Primary - PPP - CALGB-40101

Effect of age on the pharmacokinetics of busulfan (Bu): An Alliance study.

Beumer, J. H. , Lewis, L. D. , Owzar, K. , Jiang, C. , Holleran, J. L. ... - ASCO - J. Clin. Oncol. - 2012

Abstract - Secondary - Primary - PPP - CALGB-10503 , CALGB-19808 , CALGB-100103

Effect of Age on the Pharmacokinetics of Busulfan in Patients Undergoing Hematopoietic Cell Transplantation; an Alliance study (CALGB 10503, 19808, and 100103)

Beumer, Jan H. , Owzar, Kouros , Lewis, Lionel D. , Jiang, Chen ... - - Cancer Chemother. Pharmacol. - 2014

Manuscript - Secondary - Primary - PPP - C19808 , CALGB-100103 , CALGB-10503

Discovery of SNPs associated with chemotherapy-induced peripheral neuropathy (CIPN) using model estimated parameters as phenotypes CALGB 40502 (Alliance)

Bhongsatiern, Jiraganya , Carbonetto, P. , Chua, Katherina C. ... - ASCPT - CLINICAL PHARMACOLOGY & THERAPEUTICS - 2018

Abstract - Secondary-not-in-original - Primary - PPP - CALGB-40502

Polygenic Inheritance of Paclitaxel-Induced Sensory Peripheral Neuropathy Driven by Axon Outgrowth Gene Sets in CALGB 40101 (Alliance)

Chhibber, Aparna , Mefford, Joel , Stahl, Eli A. ... - - Pharmacogenomics J. - 2014

Manuscript - Secondary-not-in-original - Primary - PPP - CALGB-40101

Genome-Wide Meta-Analysis Validates a Role for S1PR1 in Microtubule Targeting Agent-Induced Sensory Peripheral Neuropathy

Chua, Katherina C. , Xiong, Chenling , Ho, Carol , Mushiroda, Taisei ... - - Clin Pharmacol Ther - 2020

Manuscript - Secondary-not-in-original - Meta-Analysis - PPP - CALGB-40101 , CALGB-40502

Clinical and Genome Wide Analysis of Cisplatin-Induced Peripheral Neuropathy in Survivors of Adult-Onset Cancer

Dolan, M. Eileen , El Charif, Omar , Wheeler, Heather E. ... - - Clin. Cancer Res. - 2017

Manuscript - Secondary-not-in-original - Primary - PPP - CALGB-90401

Whole-genome analysis informs breast cancer response to aromatase inhibition

Ellis, M. J. , Ding, L. , Shen, D. , Luo, J. Q. , Suman, V. J. ... - - Nature - 2012

Manuscript - Secondary-not-in-original - Comprehensive - PPP - ACOSOG-Z1031

Role of SULT1A1 copy number in tamoxifen treated breast cancer: findings from the North Central Cancer Treatment Group (NCCTG) adjuvant trial 89-30-52.

Goetz, M. P. , Moyer, A. M. , Weinshilboum, R. M. , Suman, V. A. ... - ASCO - J. Clin. Oncol. - 2008

Abstract - Secondary - Primary - PPP - NCCTG-89-30-52

Tamoxifen Pharmacogenetics of CYP2D6, CYP2C19, and SULTIA1: Long Term Follow-up of the North Central Cancer Treatment Group 89-30-52 Adjuvant Trial.

Goetz, M. , Suman, V. , Ames, M. , Black, J. , Safgren, S. , Kuffel, M. ... - SABCS - Cancer Res. - 2009

Abstract - Secondary - Long-Term-Followup - PPP - NCCTG-89-30-52

CYP2D6 and HOXB13/IL17BR: Combining inherited and tumor gene markers for prediction of tamoxifen resistance

Goetz, Matthew P. , Suman, Vera J. , Couch, Fergus J. ... - - Clin Cancer Res - 2008

Manuscript - Secondary - Primary - PPP - NCCTG-89-30-52

Loss of Heterozygosity at the CYP2D6 Locus in Breast Cancer: Implications for Germline Pharmacogenetic Studies

Goetz, Matthew P. , Sun, James X. , Suman, Vera J. , Silva, Grace O. ... - - J. Natl. Cancer Inst - 2014

Manuscript - Secondary-not-in-original - Primary - PPP - NCCTG-89-30-52

The impact of cytochrome P450 2D6 metabolism in women receiving adjuvant tamoxifen.

Goetz, Matthew P , Knox, Stacey K , Suman, Vera J , Rae, James M ... - - Breast Cancer Res. Treat. - 2007

Manuscript - Secondary - Primary - PPP - NCCTG-89-30-52

Genome-wide profiling of archived material from CALGB 9840 and 9342 for paclitaxel (P) and trastuzumab (T) response biomarkers using gene expression and copy number analysis

Harris, L. N. , Parker, J. R. , Broadwater, G. , Schulz, V. ... - SABCS - Cancer Res. - 2009

Abstract - Secondary-not-in-original - Comprehensive - PPP - CALGB-9342 , CALGB-9840 , CALGB-159806

Correlation of Kinase Genotype and Clinical Outcome in the North American Intergroup Phase III Trial of Imatinib Mesylate for Treatment of Advanced Gastrointestinal Stromal Tumor: CALGB 150105 Study by Cancer and Leukemia Group B and Southwest Oncology Group

Heinrich, Michael C. , Owzar, Kouros , Corless, Christopher L. ... - - J Clin Oncol - 2008

Manuscript - Secondary - Primary - PPP - CALGB-150105

A genome-wide association study (GWAS) of docetaxel-induced peripheral neuropathy in CALGB 90401 (Alliance)

Hertz, D. L. , Owzar, K. , Halabi, S. , Kelly, W. K. , Zembutsu, H. ... - ASCO - J. Clin. Oncol. - 2013

Abstract - Primary - Primary - PPP - CALGB-60404 , C90401

Association of CEP72 rs924607 with vincristine-induced peripheral neuropathy in patients with diffuse large B-cell lymphoma on Alliance/CALGB 50303

Hertz, Daniel L. , Larson, Nicholas , Pierpont, Timothy M ... - ASCO - J Clin Oncol - 2020

Abstract - Secondary-not-in-original - Primary - PPP - CALGB-50303

Pharmacogenetic Discovery in CALGB (Alliance) 90401 and Mechanistic Validation of a VAC14 Polymorphism That Increases Risk of Docetaxel-Induced Neuropathy

Hertz, Daniel L. , Owzar, Kouros , Lessans, Sherrie , Wing, Claudia ... - - Clin. Cancer Res. - 2016

Manuscript - Primary - Primary - PPP - CALGB-60404 , CALGB-90401

A genome-wide association study (GWAS) of docetaxel-induced neutropenia in CALGB 90401/60404 (Alliance).

Hertz, Daniel Louis , Jiang, Chen , Owzar, Kouros , Halabi, Susan ... - ASCO - J. Clin. Oncol. - 2014

Abstract - Primary - Primary - PPP - CALGB-60404 , CALGB-90401

Irinotecan-induced neutropenia and UGT1A1*28: Does dose matter?

Hoskins, J. M. , Goldberg, R. M. ... - - J. Clin. Oncol. - 2007

Abstract - Secondary-not-in-original - Comprehensive - PPP - N9741

UGT1A1*28 genotype and irinotecan-induced neutropenia: dose matters.

Hoskins, Janelle M , Goldberg, Richard M , Qu, Pingping ... - - J. Natl. Cancer Inst. - 2007

Manuscript - Secondary-not-in-original - Comprehensive - PPP - N9741

Heritable interleukin-17F (IL17F) gene variation is associated with overall survival (OS) in pancreatic cancer patients: Results from a genome-wide association study (GWAS) in CALGB 80303

Innocenti, F. , Owzar, K. , Cox, N. J. , Evans, P. , Kubo, M. ... - ASCO - J. Clin. Oncol. - 2009

Abstract - Secondary - Primary - PPP - CALGB-80303

A genetic analysis of gemcitabine-induced high-grade neutropenia in pancreatic cancer patients

Innocenti, F , Jiang, C , Sibley, A B , Denning, S , Etheridge, A S ... - ESMO - Ann Oncol - 2018

Abstract - Secondary-not-in-original - Primary - PPP - CALGB-80303

An Initial Genetic Analysis of Gemcitabine-Induced High-Grade Neutropenia in Pancreatic Cancer Patients in CALGB 80303 (Alliance)

Innocenti, Federico , Jiang, Chen , Sibley, Alexander B. ... - - Pharmacogenet. Genomics - 2019

Manuscript - Secondary - Primary - PPP - CALGB-80303

Genetic variation determines VEGF-A plasma levels in cancer patients

Innocenti, Federico , Jiang, Chen , Sibley, Alexander B. ... - - Sci Rep - 2018

Manuscript - Secondary-not-in-original - Primary - PPP - CALGB-80303

Genetic prediction of VEGF-A plasma levels in cancer patients CALGB 80303 (Alliance)

Innocenti, Federico , Jiang, Chen , Sibley, Alexander ... - AACR - Cancer Res - 2016

Abstract - Secondary-not-in-original - Primary - PPP - CALGB-80303

A genome-wide association study of overall survival in pancreatic cancer patients treated with gemcitabine in CALGB 80303

Innocenti, Federico , Owzar, Kouros , Cox, Nancy L. , Evans, Patrick ... - - Clin. Cancer Res. - 2012

Manuscript - Secondary - Primary - PPP - CALGB-151006 , CALGB-80303

The vitamin D receptor gene as a determinant of survival in pancreatic cancer patients: Genomic analysis and experimental validation

Innocenti, Federico , Owzar, Kouros , Jiang, Chen , Etheridge, Amy S. ... - - PLoS ONE - 2018

Manuscript - Secondary-not-in-original - Primary - PPP - CALGB-80303

A genome-wide association study (GWAS) of overall survival (OS) in 609 metastatic colorectal cancer (mCRC) patients treated with chemotherapy and biologics in CALGB 80405

Innocenti, Federico , Owzar, Kouros , Jiang, Chen ... - ASCO - J. Clin. Oncol. - 2015

Abstract - Secondary - Primary - PPP - CALGB-80405

A genome-wide association study (GWAS) of overall survival (OS) in 609 metastatic colorectal cancer (mCRC) patients treated with chemotherapy and biologics in CALGB 80405

Innocenti, Federico , Owzar, Kouros , Jiang, Chen ... - ECC - Eur J Cancer - 2015

Abstract - Secondary - Primary - PPP - CALGB-80405

A Genome-Wide Association Study (GWAS) Of Survival In Metastatic Breast Cancer (MBC) Patients Treated With Letrozole (L) With Or Without Bevacizumab (B) In CALGB 40503 (Alliance)

Innocenti, Federico , Owzar, Kouros , Jiang, Chen ... - ASCO - J. Clin. Oncol. - 2016

Abstract - Secondary-not-in-original - Primary - PPP - CALGB-40503

Genomic analysis of germline variation associated with survival of colorectal cancer patients treated with chemotherapy plus biologics in CALGB/SWOG 80405 (Alliance)

Innocenti, Federico , Sibley, Alexander B. , Patil, Sushant A. ... - - Clin Cancer Res - 2021

Manuscript - Secondary - Primary - PPP - CALGB-80405

Bevacizumab-induced hypertension and proteinuria: A genome-wide analysis of more than 1,000 patients (Alliance)

Innocenti, Federico , Wang, Jin , Sibley, Alexander B. , Jiang, Chen ... - ENA / AACR - MTCT - European Journal of Cancer - 2020

Abstract - Secondary-not-in-original - Primary - PPP - CALGB-40502 , CALGB-40503 , CALGB-80303 , CALGB-90401

Inherited genetic variation in EPHA5, FGD4 and NRDG1 and paclitaxel (P) induced peripheral neuropathy (PN): Results from a genome-wide association study (GWAS) in CALGB 40101

Kroetz, D. L. , Baldwin, R. , Owzar, K. , Jiang, C. , Zembutsu, H. ... - ASCO - J. Clin. Oncol. - 2010

Abstract - Primary - Primary - PPP - C60202 , CALGB-40101

Genetic predictors of severe skin toxicity in stage III colon cancer patients treated with cetuximab: NCCTG N0147 (Alliance)

Labadie, Julia D. , Hua, Xinwei , Harrison, Tabitha A. ... - - Cancer Epidemiol Biomarkers Prev - 2021

Manuscript - Secondary-not-in-original - Primary - PPP - N0147

Genomic characterization of HER2-positive breast cancer and response to neoadjuvant trastuzumab and chemotherapy—results from the ACOSOG Z1041 (Alliance) trial

Lesurf, R. , Griffith, O. L. , Griffith, M. , Hundal, J. , Trani, L. ... - - Ann. Oncol - 2017

Manuscript - Secondary - Primary - PPP - ACOSOG-Z1041

The genomics of response to neoadjuvant trastuzumab in HER2-positive breast cancer – results from the ACOSOG Z1041 (Alliance) trial

Lesurf, Robert , Griffith, Malachi , Griffith, Obi , Watson, Mark A. ... - SABCS - Cancer Res. - 2016

Abstract - Secondary - Primary - PPP - ACOSOG-Z1041

The genomics of response to neoadjuvant trastuzumab and chemotherapy in HER2-positive breast cancer - results from the ACOSOG Z1041 (Alliance) trial

Lesurf, Robert , Griffith, Obi , Griffith, Malachi , Trani, Lee ... - PCC - - 2016

Abstract - Secondary - Primary - PPP - ACOSOG-Z1041

The relationship of polymorphisms in ABCC2 and SLCO1B3 with docetaxel pharmacokinetics and neutropenia: CALGB 60805 (Alliance)

Lewis, L. D. , Miller, A. A. , Owzar, K. , Bies, R. R. , Markova, S. ... - - Pharmacogenet Genomics - 2013

Manuscript - Primary - Primary - PPP - CALGB-60805

The pharmacokinetics and pharmacodynamics of docetaxel (DCTX) in caucasian and African American patients with solid tumors

Lewis, L. D. , Rosner, G. L. , Miller, A. A. , Egorin, M. J. ... - - J. Clin. Oncol. - 2004

Abstract - Primary - Primary - PPP - CALGB-60805

Comparative Effects of CT Imaging Measurement on RECIST End Points and Tumor Growth Kinetics Modeling

Li, CH , Bies, RR , Wang, Y , Sharma, MR , Karovic, S , Werk, L ... - - Clin Transl Sci - 2016

Manuscript - Secondary-not-in-original - Meta-Analysis - PPP - CALGB-30203 , CALGB-30303 , CALGB-9730

Identification of a Genomic Region Between SLC29A1 and HSP90AB1 Associated with Risk of Bevacizumab-Induced Hypertension: CALGB 80405 (Alliance)

Li, Megan , Mulkey, Flora , Jiang, Chen , O'Neil, Bert H. ... - - Clin. Cancer Res. - 2018

Manuscript - Secondary-not-in-original - Meta-Analysis - PPP - CALGB-40502 , CALGB-80405 , CALGB-90401 , E5103

Genome-wide copy number analysis of circulating tumor cells from patients (pts) with metastatic breast cancer (MBC)

Magbanua, M. M. , Sosa, E. V. , Eisenbud, L. E. , Scott, J. ... - ASCO - J. Clin. Oncol. - 2011

Abstract - Secondary-not-in-original - Primary - PPP - CALGB-40502

Genomic profiling of isolated circulating tumor cells from metastatic breast cancer patients

Magbanua, Mark Jesus M. , Sosa, Eduardo V. , Roy, Ritu ... - - Cancer Res. - 2013

Manuscript - Secondary-not-in-original - Meta-Analysis - PPP - CALGB-40502 , CALGB-40503

Quality assessment metrics for whole genome gene expression profiling of paraffin embedded samples

Mahoney, D. W. , Therneau, T. M. , Anderson, S. K. , Jen, J. ... - - BMC Res Notes - 2013

Manuscript - No-Endpoint - Primary - PPP - N9831

Pharmacogenetic Predictors of Adverse Events and Response to Chemotherapy in Metastatic Colorectal Cancer: Results From North American Gastrointestinal Intergroup Trial N9741

McLeod, Howard L. , Sargent, Daniel J. , Marsh, Sharon ... - - J Clin Oncol - 2010

Manuscript - Secondary - Primary - PPP - N9741

Cellular transporter pharmacogenetics in metastatic colorectal cancer: Initial analysis of C80203

Mcleod, H. L. , Owzar, K. , Kroetz, D. L. , Innocenti, F. , Das, S. ... - ASCO - J. Clin. Oncol. - 2008

Abstract - Secondary-not-in-original - Primary - PPP - CALGB-80203

Kinetic-Pharmacodynamic Model of Chemotherapy Induced Peripheral Neuropathy in Patients with Metastatic Breast Cancer Treated with Paclitaxel, Nab-Paclitaxel or Ixabepilone: CALGB 40502 (Alliance)

Mehrotra, Shailly , Sharma, Manish R. , Gray, Elizabeth , Wu, Kehua ... - - AAPS J - 2017

Manuscript - Secondary-not-in-original - Primary - PPP - CALGB-40502

SULT1A1, CYP2C19 and disease-free survival in early breast cancer patients receiving tamoxifen

Moyer, Ann M , Suman, Vera J , Weinshilboum, Richard M ... - - Pharmacogenomics - 2011

Manuscript - Secondary-not-in-original - Primary - PPP - N89-30-52

Genetic correlates of therapeutic toxicities of stage III colon cancer (CC) patients treated with adjuvant FOLFOX+/-cetuximab (Alliance NCCTG N0147)

Newcomb, Polly A. , Sun, Wei , Hua, Xinwei , Banbury, Barbara ... - ASCO - J. Clin. Oncol. - 2017

Abstract - Secondary-not-in-original - Primary - PPP - NCCTG-N0147

A discovery study to identify clinical and genetic risk factors for bevacizumab (BEV)-related gastrointestinal (GI) hemorrhage (HEM) in metastatic castration-resistant prostate cancer (mCRPC) patients (pts) treated on CALGB 90401 (Alliance)

Patel, Jai N. , Jiang, Chen , Owzar, Kouros , Hertz, Daniel L. ... - AACR - Cancer Res. - 2016

Abstract - Secondary-not-in-original - Primary - PPP - CALGB-90401

Pharmacogenetic Study in Gastric Cancer Patients Treated with Adjuvant Fluorouracil/Leucovorin or Epirubicin/Cisplatin/Fluorouracil Before and After Chemoradiation on CALGB 80101 (Alliance)

Patel, Jai N. , Jiang, Chen , Owzar, Kouros , Mulkey, Flora ... - - Pharmacogenet Genomics - 2021

Manuscript - Secondary - Primary - PPP - CALGB-80101

Genome-wide association with survival in stage II-III colon cancer (CC) clinical trials (NCCTG N0147, Alliance for Clinical Trials in Oncology; NSABP C-08, NRG Oncology)

Penney, Kathryn , Banbury, Barbara L. , Shi, Qian ... - ASCO - J Clin Oncol - 2018

Abstract - Secondary-not-in-original - Primary - PPP - N0147

KDR genetic predictor of toxicities induced by sorafenib and regorafenib.

Quintanilha, Julia C F , Geyer, Susan , Etheridge, Amy S ... - - Pharmacogenomics J - 2022

Manuscript - Secondary-not-in-original - Primary - PPP - CALGB-80802

Genetic predictor of sorafenib-induced diarrhea and hand-foot syndrome (Alliance)

Quintanilha, Julia C. F. , Geyer, Susan , Wang, Jin ... - ASCO - J Clin Oncol - 2021

Abstract - Secondary-not-in-original - Primary - PPP - CALGB-80802

PIK3R5 genetic predictors of hypertension induced by VEGF-pathway inhibitors

Quintanilha, Julia C. F. , Racioppi, Alessandro , Wang, Jin ... - - Pharmacogenomics J - 2022

Manuscript - Secondary-not-in-original - Meta-Analysis - PPP - CALGB-40502 , CALGB-40503 , CALGB-80303 , CALGB-90401

Bevacizumab-induced hypertension and proteinuria: a genome-wide study of more than 1000 patients

Quintanilha, Julia C. F. , Wang, Jin , Sibley, Alexander B. ... - - Br J Cancer - 2022

Manuscript - Secondary-not-in-original - Meta-Analysis - PPP - CALGB-40502 , CALGB-40503 , CALGB-80303 , CALGB-90401

Genome-wide association studies of survival in 1,520 cancer patients treated with bevacizumab-containing regimens

Quintanilha, Julia C.F. , Wang, Jin , Sibley, Alexander B. , Xu, Wei ... - - Int J Cancer - 2022

Manuscript - Secondary-not-in-original - Primary - PPP - CALGB-40503 , CALGB-80303 , CALGB-80405 , ICON7

A Pharmacogenetic Prediction Model of Progression-Free Survival in Breast Cancer using Genome-Wide Genotyping Data from CALGB 40502 (Alliance)

Rashkin, Sara R. , Chua, Katherina C. , Ho, Carol , Mulkey, Flora ... - - Clin. Pharmacol. Ther. - 2019

Manuscript - Secondary - Primary - PPP - CALGB-40502

Association Between CYP2D6 Polymorphisms and Outcomes Among Women With Early Stage Breast Cancer Treated With Tamoxifen

Schroth, Werner , Goetz, Matthew P. , Hamann, Ute ... - - JAMA - 2009

Manuscript - Secondary-not-in-original - Primary - PPP - N89-30-52

Personalized Management of Chemotherapy-Induced Peripheral Neuropathy Based on a Patient Reported Outcome: CALGB 40502 (Alliance)

Sharma, Manish R. , Mehrotra, Shailly , Gray, Elizabeth , Wu, Kehua ... - - J Clin Pharmacol - 2020

Manuscript - Secondary-not-in-original - Primary - PPP - CALGB-40502

Genome-Wide Meta-Analyses Identifies Novel Taxane-Induced Peripheral Neuropathy Associated Loci

Sucheston-Campbell, L E , Clay-Gilmour, A I , Barlow, W E , Budd, G T ... - - Pharmacogenet. Genomics - 2018

Manuscript - Secondary-not-in-original - Meta-Analysis - PPP - CALGB-40101 , S0221

Meta-Analysis of Genome-Wide Association Studies of Acute Myeloid Leukemia (AML) Patients Identifies Loci Associated with Risk of 11q23/KMT2A-Translocated and Core-Binding Factor (CBF) AML (Alliance). .

Walker, Christopher J. , Wang, Junke , Clay-Gilmour, Alyssa I. ... - ASH - Blood - 2020

Abstract - Secondary-not-in-original - Meta-Analysis - PPP - CALGB-20202 , CALGB-8461 , CALGB-9665

Vatalanib population pharmacokinetics in patients with myelodysplastic syndrome: CALGB 10105 (Alliance)

Wang, X , Owzar, K. , Gupta, P. , Larson, R. A. , Mulkey, F. ... - ASCPT - Clin Pharm Therapeut - 2013

Abstract - Secondary-not-in-original - Primary - PPP - CALGB-10105

Vatalanib population pharmacokinetics in patients with myelodysplastic syndrome: CALGB 10105 (Alliance)

Wang, Xiaofeng , Owzar, Kouros , Gupta, Pankaj , Larson, Richard A ... - - Br J Clin Pharmacol - 2014

Manuscript - Secondary-not-in-original - Primary - PPP - CALGB-10105

Integration of cell line and clinical trial genome-wide analyses supports a polygenic architecture of paclitaxel-induced sensory peripheral neuropathy

Wheeler, Heather E. , Gamazon, Eric R. , Wing, Claudia ... - - Clin. Cancer Res. - 2013

Manuscript - Secondary-not-in-original - Primary - PPP - CALGB-40101

Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer

Wolpin, Brian M. , Rizzato, Cosmeri , Kraft, Peter ... - - Nat. Genet. - 2014

Manuscript - Secondary-not-in-original - Primary - PPP - C80303

Tumor and germline markers for gemcitabine sensitivity in pancreatic cancer

Yee, S. , Collisson, E. , Gysin, S. , Owzar, K. , Jiang, C. ... - PGRN - - 2009

Abstract - Secondary - Primary - PPP - CALGB-80303

Influence of genetic variation in the vitamin D pathway on plasma 25-hydroxyvitamin D3 levels and survival among patients with metastatic colorectal cancer

Yuan, Chen , Renfro, Lindsay , Ambadwar, Pratibha B. , Ou, Fang-Shu ... - - Cancer Causes Control - 2019

Manuscript - Secondary-not-in-original - Primary - PPP - N9741